Bio-Rad Laboratories, Inc.Class A Stock Prediction
AI-powered sentiment analysis and prediction trends for BIO, updated each market day.
BIO AI Sentiment
AI sees no strong directional signal for Bio-Rad Laboratories, Inc.Class A stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Bio-Rad Laboratories, Inc.Class A
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Sector
Exchange
Market Cap
$7,489,834,335
Cap Tier
Employees
7,450
Headquarters
HERCULES, CA
Listed Since
Feb. 29, 1980
Website
BIO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BIO Volatility
Bio-Rad Laboratories, Inc.Class A has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
